Similar to Seo et al., this scoring method will give a positivity rate of 10% in our cohort of breast cancer patients, but this percentage is far from the average positivity of 20–50% seen in most of the 15 studies related to ALDH1 in breast cancer that were reviewed by Liu et al. [45]. The gene discussed is ALDH1A1; the disease is breast cancer.